4.6 Article

Optimal Everolimus Concentration Is Associated With Risk Reduction for Acute Rejection in De Novo Renal Transplant Recipients

Journal

TRANSPLANTATION
Volume 90, Issue 1, Pages 31-37

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TP.0b013e3181de1d67

Keywords

Immunosuppression; Renal transplantation; Outcomes; Everolimus; Tacrolimus

Funding

  1. Novartis Pharmaceuticals Corporation

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available